why choose us

First received: March 27, 2023

Clinical Trial: A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Eosinophilic Asthma

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eos

Brief Summary: The objective of this clinical study is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma.

Read more